The American College of Obstetricians and Gynecologists (ACOG) has released its 2026 maternal immunization schedule, which includes guidance for pregnant, postpartum, and lactating patients.
Background
Maternal immunization is crucial for protecting both mothers and infants from vaccine-preventable diseases. The updated ACOG schedule aims to provide clear recommendations for healthcare providers.
Data Highlights
No numerical or trial data provided in the source material.
Key Findings
ACOG recommends four routinely administered maternal vaccines: influenza, COVID-19, Tdap, and RSV.
Influenza and COVID-19 vaccines can be administered at any gestational age.
Tdap vaccination is advised during each pregnancy between 27 and 36 weeks of gestation.
Only Pfizer’s Abrysvo is recommended for maternal RSV vaccination, ideally between 32 and 36 weeks of gestation.
ACOG's schedule is intended as an educational resource and not a definitive standard of care.
HPV vaccination should be initiated during postpartum or breastfeeding, not during pregnancy.
Clinical Implications
Healthcare providers should utilize the ACOG maternal immunization schedule to discuss vaccinations during pregnancy.
Conclusion
The 2026 maternal immunization schedule by ACOG serves as an educational resource for obstetric care.
A large Epic Cosmos analysis linked vaginal estrogen prescribing with lower rates of sepsis, hospital admission, and death following recurrent urinary tract infection, but researchers cautioned that prescribing may also mark broader differences in care.
Investigators found that adding pregnancy-related and female-specific factors modestly improved postpartum cardiovascular risk prediction compared with traditional risk factors alone.
